BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15816565)

  • 1. Pharmacokinetics and pharmacodynamics of rocuronium in patients with and without renal failure.
    Robertson EN; Driessen JJ; Booij LH
    Eur J Anaesthesiol; 2005 Jan; 22(1):4-10. PubMed ID: 15816565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics of rocuronium 0.3 mg kg(-1) in adult patients with and without renal failure.
    Robertson EN; Driessen JJ; Vogt M; De Boer H; Scheffer GJ
    Eur J Anaesthesiol; 2005 Dec; 22(12):929-32. PubMed ID: 16318664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis.
    van Miert MM; Eastwood NB; Boyd AH; Parker CJ; Hunter JM
    Br J Clin Pharmacol; 1997 Aug; 44(2):139-44. PubMed ID: 9278198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide (Org 9426) during isoflurane anaesthesia in patients with and without renal failure.
    Cooper RA; Maddineni VR; Mirakhur RK; Wierda JM; Brady M; Fitzpatrick KT
    Br J Anaesth; 1993 Aug; 71(2):222-6. PubMed ID: 8123396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-course of action of rocuronium 0.3 mg.kg-1 in children with and without endstage renal failure.
    Driessen JJ; Robertson EN; Van Egmond J; Booij LH
    Paediatr Anaesth; 2002 Jul; 12(6):507-10. PubMed ID: 12139591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of rocuronium (ORG 9426) in patients with chronic renal failure.
    Khuenl-Brady KS; Pomaroli A; PĆ¼hringer F; Mitterschiffthaler G; Koller J
    Anaesthesia; 1993 Oct; 48(10):873-5. PubMed ID: 8238829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of rocuronium after bolus and continuous infusion during halothane anaesthesia.
    McCoy EP; Mirakhur RK; Maddineni VR; Wierda JM; Proost JH
    Br J Anaesth; 1996 Jan; 76(1):29-33. PubMed ID: 8672375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of rocuronium bromide in patients with and without renal failure.
    Cooper RA; Mirakhur RK; Wierda JM; Maddineni VR
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():43-4. PubMed ID: 8557005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of rocuronium in patients with cirrhosis.
    Khalil M; D'Honneur G; Duvaldestin P; Slavov V; De Hys C; Gomeni R
    Anesthesiology; 1994 Jun; 80(6):1241-7. PubMed ID: 8010470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rocuronium pharmacokinetic-pharmacodynamic relationship under stable propofol or isoflurane anesthesia.
    Dragne A; Varin F; Plaud B; Donati F
    Can J Anaesth; 2002 Apr; 49(4):353-60. PubMed ID: 11927473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study.
    Staals LM; Snoeck MM; Driessen JJ; van Hamersvelt HW; Flockton EA; van den Heuvel MW; Hunter JM
    Br J Anaesth; 2010 Jan; 104(1):31-9. PubMed ID: 20007792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology of rocuronium (Org 9426): study of the time course of action, dose requirement, reversibility, and pharmacokinetics.
    van den Broek L; Wierda JM; Smeulers NJ; van Santen GJ; Leclercq MG; Hennis PJ
    J Clin Anesth; 1994; 6(4):288-96. PubMed ID: 7946364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hypothermic cardiopulmonary bypass on the pharmacodynamics and pharmacokinetics of rocuronium.
    Smeulers NJ; Wierda JM; van den Broek L; Gallandat Huet RC; Hennis PJ
    J Cardiothorac Vasc Anesth; 1995 Dec; 9(6):700-5. PubMed ID: 8664462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of rocuronium in young adult and elderly patients undergoing elective surgery.
    Varrique RM; Lauretti GR; Matsumoto JA; Lanchote VL; de Moraes NV
    J Pharm Pharmacol; 2016 Nov; 68(11):1351-1358. PubMed ID: 27545305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of rocuronium bromide.
    Khuenl-Brady KS; Sparr H
    Clin Pharmacokinet; 1996 Sep; 31(3):174-83. PubMed ID: 8877248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suxamethonium administration prolongs the duration of action of subsequent rocuronium.
    Robertson EN; Driessen JJ; Booij LH
    Eur J Anaesthesiol; 2004 Sep; 21(9):734-7. PubMed ID: 15595587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic/pharmacodynamic modeling of rocuronium in myasthenic patients is improved by taking into account the number of unbound acetylcholine receptors.
    De Haes A; Proost JH; Kuks JB; van den Tol DC; Wierda JM
    Anesth Analg; 2002 Sep; 95(3):588-96, table of contents. PubMed ID: 12198043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An overview of the pharmacokinetics and pharmacodynamics of rocuronium bromide].
    Iwasaki H
    Masui; 2006 Jul; 55(7):826-33. PubMed ID: 16856542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of rocuronium (Org 9426) in elderly surgical patients.
    Matteo RS; Ornstein E; Schwartz AE; Ostapkovich N; Stone JG
    Anesth Analg; 1993 Dec; 77(6):1193-7. PubMed ID: 8250312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated doses of rocuronium bromide administered to cirrhotic and control patients receiving isoflurane. A clinical and pharmacokinetic study.
    Servin FS; Lavaut E; Kleef U; Desmonts JM
    Anesthesiology; 1996 May; 84(5):1092-100. PubMed ID: 8624003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.